Big Pharma Short Sellers Get Selective
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
All Work
Chris Lange
Short Sellers Yield on Cannabis Stocks
The December 13 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Major Biotechs See Rising Short Interest
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Will Microbot Medical’s Robotic Surgery System Be a Big Hit?
Microbot Medical shares made a massive gain on Tuesday after the company revealed its Liberty system, which would be the world’s first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular…
Why This Ovarian Cancer Drug Could Be Huge for NewLink Genetics
NewLink Genetics shares jumped on Tuesday after the company announced that it entered into an exclusive worldwide license agreement with Ellipses Pharma.
Auto Sales Could Dip for December
Although retail auto sales are expected to dip for the 2019 year, there could be a silver lining, at least according to a report from J.D. Power.
Why Wedbush Now Has the Street’s Highest Apple Target
Apple is putting the finishing touches on what has been a historic year for the company and will serve as a launching pad for 2020 to be the "year of an iPhone supercycle". Wedbush…
The Top Biopharma Calendar Events to Watch Going Into 2020
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
Why This Duchenne Muscular Dystropy Deal Could Be Huge
Sarepta Therapeutics shares made a handy gain to start the week after it announced a licensing agreement with Roche for its investigational gene therapy for Duchenne muscular dystrophy.
Why This Schizophrenia Treatment Approval Is Such a Big Deal
Intra-Cellular Therapy shares practically doubled on Monday after the firm announced that the FDA has approved Caplyta for the treatment of schizophrenia in adults
Meet the Biggest and Best Blockchain ETFs of 2019
Although the hype for the blockchain has subsided recently, the potential for the technology is touted as being nearly unlimited. In the course of choosing where to invest for this theme specifically, there are…
The First Ebola Vaccine Has Been Approved in the US
NewLink Genetics and Merck shares made handy gains on Friday after it was announced that the FDA has granted approval to Ervebo, the Zaire Ebola virus vaccine V920.
Is Stealth Bio Done After Mitochondrial Myopathy Study?
Stealth Bio shares were absolutely crushed on Friday after the firm announced results from its late-stage study in patients with primary mitochondrial myopathy (PMM). Specifically, the top-line results are coming from the Phase 3…
Carnival Sails Away With Q4 Earnings
Carnival shares rallied after it reported better than expected quarterly results with rosy earnings guidance late on Thursday.
Micron Cruises By With Q1 Earnings
Micron released better than expected fiscal first-quarter financial results after markets closed Wednesday.
What to Expect When Nike Reports Thursday
Nike is scheduled to release its fiscal first-quarter financial results after the markets close on Tuesday, and analysts are looking for solid year-over-year growth.
Meet the Newest Collaboration in the Fight Against Sickle Cell Disease
Syros Pharma and Global Blood Therapeutics shares were on the move on Wednesday after the companies announced a collaboration to develop and commercialize novel therapies for sickle cell disease and beta thalassemia.
What to Watch When Micron Reports After the Close
Micron is scheduled to release its fiscal first-quarter financial results after the closing bell on Wednesday.
Is Solid Biosciences in Trouble After This Duchenne Muscular Dystrophy Update?
Solid Biosciences shares jumped on Wednesday after the firm provided an update from its midstage study in Duchenne muscular dystrophy.
Amazon Rolls Out Free Return Policy Ahead of Christmas
Just in time for Christmas, Amazon announced that it is making buying—and returning—gifts on its platform even easier.